Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization.

Analytical and bioanalytical chemistry·2026
Same author

Metabolic engineering of Saccharomyces cerevisiae sphingolipid pathways for enhanced phytoceramide production.

New biotechnology·2026
Same author

Covalent functionalization of polymeric nanoparticles prepared from nano-emulsion templates for gene silencing and antioxidant delivery at neuronal level.

International journal of pharmaceutics·2026
Same author

Transforming tumor cells into professional antigen-presenting cells using poly(β-amino ester) nanoparticles to deliver CD80-encoding mRNA.

Nanoscale horizons·2026
Same author

Serial intravital microscopy reveals temporal dynamics of autoreactive germinal centers in the spleen.

iScience·2026
Same author

A dual QTOF-QTrap analytical platform for comprehensive tracking of doxycycline and its degradation byproducts in biological and nanoparticle-based delivery systems.

Talanta·2026

Related Experiment Video

Updated: Jun 16, 2025

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.5K

Stealth mRNA nanovaccines to control lymph node trafficking.

Coral García-Fernández1, Tommaso Virgilio2, Irene Latino2

  • 1Grup d'Enginyeria de Materials (Gemat), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL). Via Augusta, Barcelona, Catalonia, 08017, Spain; Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Universita della Svitzzera italiana (USI) - Switzerland, Via Francesco Chiesa 5, Bellinzona 6500, Suiza.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|August 18, 2024
PubMed
Summary

This study introduces a novel mRNA vaccine delivery system that precisely targets antigen-presenting cells (APCs) in lymph nodes. This controlled approach minimizes inflammation and enhances immune responses for improved cancer vaccines.

Keywords:
(zwitterionicsDelivery systemsNanoparticlesReactogenicity)cancermRNA

More Related Videos

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

11.0K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K

Related Experiment Videos

Last Updated: Jun 16, 2025

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.5K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

11.0K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K

Area of Science:

  • Nanomedicine
  • Vaccinology
  • Immunology

Background:

  • mRNA vaccines offer a new approach to personalized medicine but face limitations due to reactogenicity.
  • Current mRNA vaccine formulations can cause significant inflammation, restricting their use in areas like tumor therapeutics.

Purpose of the Study:

  • To develop an mRNA delivery system with controlled immunogenicity and minimal inflammation.
  • To enable selective delivery of mRNA to antigen-presenting cells (APCs) in lymph nodes.
  • To enhance the efficacy of mRNA vaccines for therapeutic applications, particularly anti-tumoral vaccines.

Main Methods:

  • Development of a nanoparticle-based delivery system with optimized stealth and targeting properties.
  • Control over nanoparticle trafficking and opsonization within lymph nodes.
  • Spatial programming of nanoparticle distribution to target specific APCs in the medullary region.

Main Results:

  • Demonstrated controlled immunogenicity with minimal non-specific inflammation.
  • Achieved selective delivery of mRNA to APCs within lymph nodes.
  • Observed a potent adaptive and humoral immune response upon targeted delivery.
  • Showcased improved and expanded utilization of mRNA vaccines through spatial programming.

Conclusions:

  • The developed delivery system offers precise control over mRNA vaccine immunogenicity and biodistribution.
  • Targeted delivery to APCs promotes robust adaptive and humoral immune responses.
  • This platform holds significant promise for developing effective preventive and therapeutic anti-tumoral mRNA vaccines.
  • Represents a significant advancement in targeted nanomedicine for vaccine development.